Identifying SERPINA1 as a Marker for Papillary Thyroid Carcinoma
Author Information
Author(s): Vierlinger Klemens, Mansfeld Markus H, Koperek Oskar, Nöhammer Christa, Kaserer Klaus, Leisch Friedrich
Primary Institution: AIT - Austrian Institute of Technology
Hypothesis
Can SERPINA1 be identified as a reliable marker for papillary thyroid carcinoma through meta-analysis of microarray data?
Conclusion
The study confirms SERPINA1 as a potent mRNA marker for papillary thyroid carcinoma with high accuracy in distinguishing it from benign nodules.
Supporting Evidence
- SERPINA1 was identified with 99% accuracy in distinguishing papillary thyroid carcinoma from benign nodules.
- In independent validation, SERPINA1 showed 93% accuracy in identifying papillary thyroid carcinoma.
- The study utilized a meta-analysis approach to combine data from multiple studies for more robust results.
Takeaway
Researchers found a gene called SERPINA1 that can help tell if someone has a type of thyroid cancer called papillary thyroid carcinoma, and it works really well.
Methodology
The study used a meta-analysis approach on four publicly available microarray datasets and validated findings with quantitative RT-PCR.
Potential Biases
The study acknowledges the risk of biases due to the heterogeneous nature of the patient cohorts and control material.
Limitations
The study faced challenges with sample heterogeneity and potential biases in the datasets used.
Participant Demographics
The study included samples from various thyroid entities, including papillary thyroid carcinoma and benign nodules.
Statistical Information
P-Value
1.3 * 10-10
Statistical Significance
p = 1.3 * 10-10
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website